BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29660832)

  • 1. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
    Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
    Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
    Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
    J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
    Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
    Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
    J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
    Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X; Ma F; Bai M; Wang Y; Jia Q; Dong R; Liu C; Sun S
    Ren Fail; 2021 Aug; 43(1):1180-1187. PubMed ID: 34376108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
    Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
    Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes.
    Yokoyama H; Kanno S; Takahashi S; Yamada D; Honjo J; Saito K; Sone H; Haneda M
    Nephrol Dial Transplant; 2011 Sep; 26(9):2924-30. PubMed ID: 21303964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
    J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.